Reporting of Harmonising Outcome Measures for Eczema (HOME) core outcome set instruments in randomized clinical trials for systemic treatments in atopic dermatitis
Megan Lam, Phyllis I Spuls, Yael A Leshem, Louise A A Gerbens, Kim S Thomas, Bernd Arents, Tim Burton, Carsten Flohr, Aaron M Drucker
British Journal of Dermatology
494 - 496
Further Study Information
This work was supported through a UK National Institute for Health Research Career Development Fellowship held by C.F. (CDF-2014-07-037). Knowledge translation components of this work are funded by the Eczema Society of Canada and the Innovation Fund of the Alternate Funding Plan for the Academic Health Sciences Centres of Ontario.
Disease Category: Skin
Disease Name: Atopic dermatitis
Age Range: Unknown
Nature of Intervention:
- COS uptake study
- Systematic review
We included RCTs with publicly available results in 2018 or after in a living systematic review and network meta-analysis (NMA) of RCTs of systemic treatments for AD. For each included RCT, we evaluated data reported in trial registries, published conference abstracts and peer-reviewed publications.